Monoclonal Antibodies - Protein Synthesis

A Functional Site on the Human TSH Receptor: A Potential Therapeutic Target in Graves' Disease
A Functional Site on the Human TSH Receptor: A Potential Therapeutic Target in Graves' Disease Posted 11/13/2003 Alan P. Johnstone, Jeremy C. Cridland, Clive R. Da Costa, Stephen S. Nussey, Phili
A rapid and efficient method for generating anti-variable region monoclonal antibodies using type-1 interferons as immune modulators
A rapid and efficient method for generating anti-variable region monoclonal antibodies using type-1 interferons as immune modulators 2006 Staquet K, Fisher J, Lamb R, Bannish G, Duchala C, Mbow M
AbMiner: A bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies
AbMiner: A bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies 6 April 2006 Sylvia M Major1 ,4 , Satoshi
Administration of antibody to the lung protects mice against pneumonic plague
Administration of antibody to the lung protects mice against pneumonic plague 2006 May Hill J, Eyles JE, Elvin SJ, Healey GD, Lukaszewski RA, Titball RW. Infect Immun. Intratracheal delivery of
Advances in cancer therapy with radiolabeled monoclonal antibodies
Advances in cancer therapy with radiolabeled monoclonal antibodies 2006 Dec Goldenberg DM, Sharkey RM. Center for Molecular Medicine and Immunology, Garden State Cancer Center, Belleville, NJ, U
Anticancer Antibodies
Anticancer Antibodies Posted 04/17/2003 Jeffrey S. Ross, MD, Karen Gray, PhD, Gary S. Gray, PhD, Peter J. Worland, PhD, Mark Rolfe, PhD American Journal of Clinical Pathology Abstract The recen
Antigen-based immunofluorescence analysis of B-cell targeting: advanced technology for the generation of novel monoclonal antibodies with high efficiency and selectivity
Antigen-based immunofluorescence analysis of B-cell targeting: advanced technology for the generation of novel monoclonal antibodies with high efficiency and selectivity 2006 Oct Tomita M, Fukuda
Application of monoclonal antibody immobilized polyurethane film for site-specific gene therapy
Application of monoclonal antibody immobilized polyurethane film for site-specific gene therapy 2006 Jun Zhang LH, Song CX, Wang MY, Yang J, Tang LN. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. OBJECT
Bevacizumab combination therapy in heavily pretreated, recurrent cervical cancer
Bevacizumab combination therapy in heavily pretreated, recurrent cervical cancer 2 May 2006 Jason D. Wright, Dana Viviano, Matthew A. Powell, Randall K. Gibb, David G. Mutch, Perry W. Grigsby and
Bispecific and human disease-related anti-keratin rabbit monoclonal antibodies
Bispecific and human disease-related anti-keratin rabbit monoclonal antibodies 15 February 2006 Guo-Zhong Tao, Ikuo Nakamichi, Nam-On Ku, Jing Wang, Maria Frolkis, Xiaosong Gong, Weimin Zhu, Rober
Calumin, a novel Ca2+-binding transmembrane protein on the endoplasmic reticulum
Calumin, a novel Ca2+-binding transmembrane protein on the endoplasmic reticulum Received 21 June 2006; revised 10 October 2006; accepted 22 November 2006. Available online 3 January 2007 Miao
Characterization of a monoclonal antibody with specificity for holo-transcobalamin
Characterization of a monoclonal antibody with specificity for holo-transcobalamin January 4, 2006 Lars Orning , Anne Rian , Andrew Campbel , Jeff Brady , Sergey N Fedosov , Birgit Bramlage , Ke
Characterization of Anti-TIMP-1 Monoclonal Antibodies for Immunohistochemical Localization in Formalin-fixed, Paraffin-embedded Tissue
Characterization of Anti-TIMP-1 Monoclonal Antibodies for Immunohistochemical Localization in Formalin-fixed, Paraffin-embedded Tissue 2006 Irene Vejgaard Sorensen, Claus Fenger, Henrik Winther, N
Chimpanzee Monoclonal Antibodies Protect Against Anthrax Challenge
Chimpanzee Monoclonal Antibodies Protect Against Anthrax Challenge 2006 By Will Boggs, MD J Infect Dis NEW YORK (Reuters Health) Mar 31 - Chimpanzee monoclonal antibodies against anthrax toxin p
Combination Antibody-Based Therapy Destroys Tumors in Mice
Combination Antibody-Based Therapy Destroys Tumors in Mice 2006 Nat Med NEW YORK (Reuters Health) May 11 - Researchers have shown that combination therapy with monoclonal antibodies that trigger
Comparison of intratumoral bolus injection and convection-enhanced delivery of radiolabeled antitenascin monoclonal antibodies
Comparison of intratumoral bolus injection and convection-enhanced delivery of radiolabeled antitenascin monoclonal antibodies 2006 Apr 15 Sampson JH, Akabani G, Friedman AH, Bigner D, Kunwar S, B
Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412
Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412 September 7, 2006 Ganesh Suntharalingam, F.R.C.A., Meghan R. Perry, M.R.C.P., Stephen Ward, F.R.C.A., Stephen J. Bre
Development and characterization of rat monoclonal antibodies to denatured mouse angiotensin-converting enzyme
Development and characterization of rat monoclonal antibodies to denatured mouse angiotensin-converting enzyme 2005 Balyasnikova IV; Metzger R; Sun ZL; Berestetskaya YV; Albrecht RF; Danilov SM T
Development of human monoclonal antibodies against diseases caused by emerging and biodefense-related viruses.
Development of human monoclonal antibodies against diseases caused by emerging and biodefense-related viruses. Zhu Z, Dimitrov AS, Chakraborti S, Dimitrova D, Xiao X, Broder CC, Dimitrov DS. Febru
Downstream processing of monoclonal antibodies-Application of platform approaches
Downstream processing of monoclonal antibodies-Application of platform approaches 2006 Oct 12 Shukla AA, Hubbard B, Tressel T, Guhan S, Low D. Process Development, Amgen Inc., 1201 Amgen Court W
Drug Carriers in Medicine and Biology
Volker Schellenberger at Genencor International discussed the use of mAb-enzyme fusion proteins for the activation of anticancer prodrugs within solid tumors. The major issues in this field are immuno
Endovascular microcoil applied for gene delivery system
Endovascular microcoil applied for gene delivery system 2005 Apr Mei L, Sun HF, Tang LN, Yang J, Chang J, Song CX. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. OBJECTIVE: To explore the possibility of
Epitope mapping and features of the epitope for monoclonal antibodies inhibiting enzymatic activity of Helicobacter pylori urease
Epitope mapping and features of the epitope for monoclonal antibodies inhibiting enzymatic activity of Helicobacter pylori urease 2004 Fujii R; Morihara F; Oku T; Hifumi E; Uda T Fukuyama Medical
FGF-1 as a possible carrier for targeted drug delivery
FGF-1 as a possible carrier for targeted drug delivery 2006 Marcinkowska E, Superat K, Wiedlocha A. Oncol Res. Delivery of anticancer chemotherapeuticals to tumor cells raises many problems due
Generation of Monoclonal Antibody Recognized by the GXXXG Motif (Glycine Zipper) of Prion Protein
Generation of Monoclonal Antibody Recognized by the GXXXG Motif (Glycine Zipper) of Prion Protein 2006 Oct Choi JK, Park SJ, Jun YC, Oh JM, Jeong BH, Lee HP, Park SN, Carp RI, Kim YS. Ilsong Ins
Hormone refractory prostate cancer: Management and advances
Hormone refractory prostate cancer: Management and advances April 2006 Guru Sonpavde, Thomas E. Hutson and William R. Berry Cancer Treatment Reviews Summary Effective therapeutic options have n
Human monoclonal antibodies to domain C of tenascin-C selectively target solid tumors in vivo
Human monoclonal antibodies to domain C of tenascin-C selectively target solid tumors in vivo 2006 Aug 22 Silacci M, Brack SS, Spath N, Buck A, Hillinger S, Arni S, Weder W, Zardi L, Neri D. Pro
Infectious complications related to nucleoside analogs and monoclonal antibodies
Infectious complications related to nucleoside analogs and monoclonal antibodies 2006 Oct 27 Maschmeyer G, Haas A. Medizinische Klinik, Abt. Hamatologie und Onkologie, Klinikum Ernst von Bergman
Investigational Monoclonal Antibody Lowers HIV Load
Investigational Monoclonal Antibody Lowers HIV Load Dec. 19, 2005 By Deborah Mitchell WASHINGTON (Reuters Health) Dec 19 - When given with optimized background antiretroviral therapy, an investig
Marburgvirus nucleoprotein-capture enzyme-linked immunosorbent assay using monoclonal antibodies to recombinant nucleoprotein: detection of authentic marburgvirus
Marburgvirus nucleoprotein-capture enzyme-linked immunosorbent assay using monoclonal antibodies to recombinant nucleoprotein: detection of authentic marburgvirus 2006 Oct Saijo M, Georges-Courbot
Mechanisms of Aggregate Formation and Carbohydrate Excipient Stabiliza-tion of Lyophilized Humanized Monoclonal Antibody Formulations
Mechanisms of Aggregate Formation and Carbohydrate Excipient Stabiliza-tion of Lyophilized Humanized Monoclonal Antibody Formulations April 2003 James D. Andya1, Chung C. Hsu1, and Steven J. Shire1
Medical Treatment of Advanced Renal Cell Carcinoma: Present Options and Future Directions
Medical Treatment of Advanced Renal Cell Carcinoma: Present Options and Future Directions June 2006 Francesco M. Boccardo, Pamela Guglielmini and Laura Tacchini European Urology Supplements Abst
Modulation of hybridoma cell growth and antibody production by coating cell culture material with extracellular matrix proteins
Modulation of hybridoma cell growth and antibody production by coating cell culture material with extracellular matrix proteins Received 18 May 2006; revised 21 December 2006; accepted 16 January
Monoclonal antibodies and fusion proteins in medicine
Monoclonal antibodies and fusion proteins in medicine October 2005 Stamatis-Nick C. Liossis and George C. Tsokos Journal of Allergy and Clinical Immunology Abstract Humanized antibodies and dec
Monoclonal antibodies to mechano-growth factor
Monoclonal antibodies to mechano-growth factor 2006 Oct Kravchenko IV, Furalyov VA, Khotchenkov VP, Popov VO. A.N. Bach Institute of Biochemistry, Russian Academy of Sciences, Moscow, Russia Hy
Monoclonal antibody combinations in CLL: evolving strategies
Monoclonal antibody combinations in CLL: evolving strategies Available online 22 September 2006. Stefan Faderl MD, a, , Associate Professor, Susan O'Brien MDa, Professor and Michael J. Keating MB
Monoclonal Antibody Combo Promising Against Rabies
Monoclonal Antibody Combo Promising Against Rabies 2006 J Infect Dis NEW YORK (Reuters Health) Apr 06 - Studies in hamsters show that a combination of two human monoclonal antibodies (MAbs) may o
Monoclonal antibody HCV-Ab(XTL)68 in patients undergoing liver transplantation for HCV: Results of a phase 2 randomized study
Monoclonal antibody HCV-Ab(XTL)68 in patients undergoing liver transplantation for HCV: Results of a phase 2 randomized study 2006 Aug 24 Schiano TD, Charlton M, Younossi Z, Galun E, Pruett T, Tur
Monoclonal Antibody Reduces Exacerbations In Asthmatics, Study Finds
Monoclonal Antibody Reduces Exacerbations In Asthmatics, Study Finds October 10, 2006 Science Daily Patients with symptomatic moderate asthma who were treated with anti-tumor necrosis factor alp
Multiple myeloma: Monoclonal antibodies-based immunotherapeutic strategies and targeted radiotherapy
Multiple myeloma: Monoclonal antibodies-based immunotherapeutic strategies and targeted radiotherapy 2006 Jul Chatterjee M, Chakraborty T, Tassone P. Eur J Cancer. Multiple myeloma (MM) is an i
New drug brings relief to carcinoma patients
New drug brings relief to carcinoma patients September 20, 2006 Biopeer Epithelial cancers, also called carcinomas, are the most widespread of all cancers. Carcinomas account for about 85 per cen
Potent Neutralization of Hendra and Nipah Viruses by Human Monoclonal Antibodies
Potent Neutralization of Hendra and Nipah Viruses by Human Monoclonal Antibodies January 2006 Zhongyu Zhu, Antony S. Dimitrov, Katharine N. Bossart, Gary Crameri,Kimberly A. Bishop, Vidita Choudhr
Potential adverse events with biologic response modifiers
Potential adverse events with biologic response modifiers 2 May 2006 James S.W. Kong, Suzanne S. Teuber and M. Eric Gershwin Autoimmunity Reviews Abstract In recent years, an explosion of biolo
Preparation and Characterization of Four Novel Monoclonal Antibodies Specific to N51(L6)C46 Polypeptide Simulating Fusogenic Core Structure of GP41 Subunit of HIV-1
Preparation and Characterization of Four Novel Monoclonal Antibodies Specific to N51(L6)C46 Polypeptide Simulating Fusogenic Core Structure of GP41 Subunit of HIV-1 2006 Oct Chen Z, Hong L, Li Z,
Preparation of monoclonal antibodies against human mesenchymal stem cells
Preparation of monoclonal antibodies against human mesenchymal stem cells 2006 Sep Liao ZX, Shen JG, Lai XY, Huang H. Institute of Immunology, College of Medicine, Zhejiang University, Hangzhou
Production and characterization of monoclonal antibodies against different epitopes of Ebola virus antigens
Production and characterization of monoclonal antibodies against different epitopes of Ebola virus antigens Received 17 October 2006; revised 31 January 2007; accepted 5 February 2007. Available
Production and Characterization of Monoclonal Antibodies to Chlamydia trachomatis
Production and Characterization of Monoclonal Antibodies to Chlamydia trachomatis 2006 Oct Kumar A, Mittal A. Institute of Pathology-ICMR, Safdarjang Hospital Campus, New Delhi, India Hybridoma
Production of monoclonal antibodies against Rift Valley fever virus Application for rapid diagnosis tests (virus detection and ELISA) in human sera
Production of monoclonal antibodies against Rift Valley fever virus Application for rapid diagnosis tests (virus detection and ELISA) in human sera 2006 Zaki A; Coudrier D; Yousef AI; Fakeeh M; Bo
Protective and immunochemical activities of monoclonal antibodies reactive with the Bacillus anthracis polypeptide capsule
Protective and immunochemical activities of monoclonal antibodies reactive with the Bacillus anthracis polypeptide capsule 2006 Oct 23 Kozel TR, Thorkildson P, Brandt S, Welch WH, Lovchik JA, Auco
Rabbit Monoclonal Antibodies
Rabbit Monoclonal Antibodies 08/24/2005 Sabrina Rossi, MD; Licia Laurino, MD; Alberto Furlanetto, MD; Serena Chinellato; Enrico Orvieto, MD; Fabio Canal, MD; Fabio Facchetti, MD; Angelo P. Dei Tos
Recent developments in colorectal cancer treatment by monoclonal antibodies
Recent developments in colorectal cancer treatment by monoclonal antibodies 2006 Nov Arsene D, Galais MP, Bouhier-Leporrier K, Reimund JM. Centre Hospitalier Universitaire de Caen, Service d'Hep
Refractory sweet syndrome with autoimmune organizing pneumonia treated with monoclonal antibodies to tumor necrosis factor
Refractory sweet syndrome with autoimmune organizing pneumonia treated with monoclonal antibodies to tumor necrosis factor 2004 Dec Karamlou K, Gorn AH. From the Division of Rheumatology, Depart
Targeted therapies in solid tumors: Monoclonal antibodies and small molecules
Targeted therapies in solid tumors: Monoclonal antibodies and small molecules 2006 Weiner LM, Borghaei H. Hum Antibodies. The considerable progress in our understanding of the complex cellular
The antigen binding sites of various hCG monoclonal antibodies show homology to different domains of LH receptor
The antigen binding sites of various hCG monoclonal antibodies show homology to different domains of LH receptor 2006 Oct 10 Gadkari RA, Sandhya S, Sowdhamini R, Dighe RR. Molecular Reproduction
The Future of Monoclonal Antibodies Therapeutics: New Publication Announcement from Piribo
The Future of Monoclonal Antibodies Therapeutics: New Publication Announcement from Piribo (PRWEB) August 23, 2006 -- The monoclonal antibody (mAb) market has grown rapidly in recent years, reachin
The Making of a Monoclonal Antibody
The Making of a Monoclonal Antibody June 13, 2006 By Sharon Reynolds NCI Cancer Bulletin n cancer treatment today, three letters have infiltrated the oncology dialect: "mab," as in bevacizumab (
The new era in the treatment of advanced colorectal cancer patients: the role of monoclonal antibodies
The new era in the treatment of advanced colorectal cancer patients: the role of monoclonal antibodies 2006 Nov Vincenzi B, Schiavon G, Silletta M, Santini D, Tonini G. University Campus Bio-Med
Validation of immunoassays used to assess immunogenicity to therapeutic monoclonal antibodies
Validation of immunoassays used to assess immunogenicity to therapeutic monoclonal antibodies 15 September 2005 Dong Geng, Gopi Shankar, Allen Schantz, Manoj Rajadhyaksha, Hugh Davis and Carrie Wa
What have we learned in dermatology from the biologic therapies?
What have we learned in dermatology from the biologic therapies? March 2006 Brian J. Nickoloff and Seth R. Stevens Journal of the American Academy of Dermatology Abstract Recent advances in our